News

From an in-depth analysis of ADHD in clinical practice to differences in effectiveness between intravenous and intranasal ketamine, here are highlights from the week in Psychiatric Times.

“The pervasive feeling shared by all is that regardless of your personal journey and experiences with mental health, you are not alone.”

The investigators suggested that future research explore the connection between ADHD risk in children and depression in pregnant parents.

Take a look at this bread-and-butter case of ADHD from a child psychiatry clinic.

Screening for the symptom of worthlessness could save your adolescent patient’s life…

Does research support the efficacy of NAC for negative symptoms in clozapine-resistant patients with schizophrenia?

An argument against “slippery slope” for medical aid in dying.

Does childhood trauma affect outcomes in bipolar disorder? Researchers analyzed the impact of childhood trauma on outcomes in outpatients with bipolar disorder treated with lithium or quetiapine in a randomized clinical trial.

Further arguments against MAID.

This latest submission completes the FDA filing that was initiated in May.

Is MAID treatment?

The holidays came early: our December issue is now live!

Psychiatric Times welcomes new partnership with ADAA.

New Year’s may be a customary time to start improving your life—but think how much better you will feel if you start today.

An argument against medical aid in dying.

Unity with the military helped a Northeastern Hospital during the COVID-19 pandemic.

What happened in 1922, and how do these events look 100 years later?

Does route of administration affect antidepressant efficacy of ketamine? Researchers performed a meta-analysis of trials comparing intravenous and intranasal administration.

Mental illness is medically real.

From evidence-based novel therapies for bipolar depression to potential indicators of early-stage Alzheimer disease, here are highlights from the week in Psychiatric Times.

“Hunter’s book is excellently written and highly recommended for readers who want to understand the enormous power of myth in the Australian identity.”

Here’s why most of the claims recently made about antidepressants in Newsweek are wrong.

The first patient in a phase 2/3 study evaluating ulotaront for MDD has been enrolled.

Merriam-Webster’s Word of 2022: gaslighting.

Perhaps we should try to act more like manatees…

Don’t grow old in your relationship, grow bold.

New research finds that a urine test for formic acid could detect early-stage Alzheimer disease.

The drug is in development for the treatment of acute depressive disorders and depression with suicidality.

The phase 3 SERENITY III trial investigating at-home use of dexmedetomidine (BXCL501) sublingual film for agitation associated with bipolar I or II disorder or schizophrenia has started.